Thalys Medical Technology Group Inc. (603716.SS)
CNY 9.69
(-3.77%)
CNY 9.69
(-3.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 125.88 Million | 28.12 Million | -133.52 Million | 9.94 Million | 93.92 Million | -63.82 Million |
| Net Income | -156.77 Million | -191.25 Million | -38.37 Million | 82.03 Million | 142.44 Million | 116.42 Million |
| Depreciation & Amortization | 74.71 Million | 84.35 Million | 96.28 Million | 76.58 Million | 66.12 Million | 58.88 Million |
| Deferred income taxes | -75.18 Million | -39.79 Million | -29.01 Million | -16.83 Million | -12.98 Million | -4.25 Million |
| Stock-based compensation | 10.33 Million | 4.58 Million | - | - | - | - |
| Change in working capital | -7.72 Million | -127.03 Million | -396.11 Million | -277.4 Million | -199.13 Million | -298.9 Million |
| Other non-cash items | 85.88 Million | 297.28 Million | 204.68 Million | 128.72 Million | 84.49 Million | 59.76 Million |
| Investing Cash Flow | 15.19 Million | 159.7 Million | -114.71 Million | -288.97 Million | -282.4 Million | -228.79 Million |
| Investments in PPE | -40.82 Million | -54.64 Million | -60.18 Million | -127.7 Million | -96.49 Million | -118.54 Million |
| Acquisitions | 3.65 Million | -16.72 Million | 2.65 Million | 3.43 Million | -35.22 Million | -82.57 Million |
| Investment purchases | -63.97 Million | -46.1 Million | -61.54 Million | -197.26 Million | -87.47 Million | -28.65 Million |
| Sales/Maturities of investments | 59.85 Million | 20.8 Million | 76 Million | 32.38 Million | 5.54 Million | 37.6 Thousand |
| Other Investing Activities | 59.82 Million | 256.38 Million | -71.64 Million | 165.34 Thousand | -68.75 Million | 935.81 Thousand |
| Financing Cash Flow | -214.3 Million | -316.63 Million | 61.39 Million | 440.95 Million | 4.71 Million | 775.87 Million |
| Debt repayment | -105.54 Million | -1.12 Billion | -939.2 Million | -1.39 Billion | -759.38 Million | -363.04 Million |
| Dividends payments | -38.79 Million | -52.25 Million | -49.52 Million | -15.86 Million | -50.1 Million | -37.21 Million |
| Common Stock Repurchased | - | - | -50.26 Million | - | -121.96 Million | -88.04 Million |
| Common Stock Issuance | - | - | 50.26 Million | - | 121.96 Million | - |
| Other Financing Activities | -69.96 Million | 859.86 Million | 1.05 Billion | 1.89 Billion | 814.2 Million | 1.17 Billion |
| Accounts receivables | 5.19 Million | -170.04 Million | -457.82 Million | -445.06 Million | -243.87 Million | -272.36 Million |
| Accounts payables | -16.88 Million | 39.9 Million | 151.89 Million | 237.62 Million | 131.13 Million | 42.74 Million |
| Inventory | 79.14 Million | 42.89 Million | -61.16 Million | -53.13 Million | -73.4 Million | -65.03 Million |
| Other working capital | -92.06 Million | -39.79 Million | -29.01 Million | -16.83 Million | -12.98 Million | -233.87 Million |
| Cash at beginning of period | 337.09 Million | 465.87 Million | 652.75 Million | 490.83 Million | 674.59 Million | 191.33 Million |
| Cash at end of period | 263.83 Million | 337.09 Million | 465.87 Million | 652.75 Million | 490.83 Million | 674.59 Million |
| Capital Expenditure | -40.82 Million | -54.64 Million | -60.18 Million | -127.7 Million | -96.49 Million | -118.54 Million |
| Effect of forex changes on cash | -36.16 Thousand | 27.57 Thousand | -25.02 Thousand | -0.07 | 74.39 | - |
| Net cash flow / Change in cash | -73.26 Million | -128.77 Million | -186.87 Million | 161.92 Million | -183.76 Million | 483.25 Million |
| Free Cash Flow | 85.06 Million | -26.52 Million | -193.71 Million | -117.75 Million | -2.56 Million | -182.37 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -51.25 Million | -7.92 Million | 3.15 Million | -156.77 Million | -154.75 Million | -5.34 Million |
| Depreciation & Amortization | - | 16.74 Million | 16.74 Million | 74.71 Million | 74.71 Million | -36.25 Million |
| Deferred income taxes | 5.84 Million | - | - | -75.18 Million | - | - |
| Stock-based compensation | - | - | - | - | 10.33 Million | - |
| Change in working capital | - | -16.86 Million | - | -7.72 Million | 84.33 Million | -31.3 Million |
| Other non-cash items | 94.77 Million | 2.91 Million | -30.3 Million | 85.88 Million | 22.22 Million | 55.92 Million |
| Investing Cash Flow | 15.84 Million | -4.09 Million | -3.64 Million | 15.19 Million | -1.13 Million | -13.28 Million |
| Investments in PPE | -8.65 Million | -1.39 Million | -3.75 Million | -40.82 Million | -20.82 Million | -9.51 Million |
| Acquisitions | 8.41 Million | 3.32 Million | 344.85 Thousand | 3.65 Million | 3.43 Million | -402.66 Thousand |
| Investment purchases | - | -11.27 Million | - | -63.97 Million | -45.36 Million | -8.67 Million |
| Sales/Maturities of investments | -2.15 Million | 5.25 Million | 27.03 Thousand | 59.85 Million | 53.47 Million | 6.37 Million |
| Other Investing Activities | 18.23 Million | -3.2 Million | 107.03 Thousand | 59.82 Million | 10.08 Million | -1.06 Million |
| Financing Cash Flow | -4.22 Million | 47.71 Million | -63.39 Million | -214.3 Million | 43.08 Million | -24.37 Million |
| Debt repayment | -26.12 Million | -111.63 Million | -35.03 Million | -105.54 Million | -24.86 Million | -24.22 Million |
| Dividends payments | - | -47.73 Million | -5.22 Million | -38.79 Million | -8.88 Million | -10.33 Million |
| Common Stock Repurchased | 29.72 Million | -29.72 Million | - | - | - | -1.4 Million |
| Common Stock Issuance | - | - | - | - | - | 1.4 Million |
| Other Financing Activities | -60.07 Million | -22.2 Million | -23.12 Million | -69.96 Million | 76.83 Million | 10.19 Million |
| Accounts receivables | - | -34.19 Million | - | 5.19 Million | 5.19 Million | -23.98 Million |
| Accounts payables | - | - | - | -16.88 Million | - | - |
| Inventory | - | 17.33 Million | - | 79.14 Million | 79.14 Million | -7.31 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 205.37 Million | 175.35 Million | 263.83 Million | 337.09 Million | 195.36 Million | 250 Million |
| Cash at end of period | 253.62 Million | 205.37 Million | 169.64 Million | 263.83 Million | 263.83 Million | 195.36 Million |
| Capital Expenditure | -8.65 Million | -1.39 Million | -3.75 Million | -40.82 Million | -20.82 Million | -9.51 Million |
| Effect of forex changes on cash | - | 63.91 | 41.16 | -36.16 Thousand | -409.37 | -192.51 |
| Net cash flow / Change in cash | 48.24 Million | 30.02 Million | -94.18 Million | -73.26 Million | 68.46 Million | -54.63 Million |
| Free Cash Flow | 40.71 Million | -23.14 Million | -30.9 Million | 85.06 Million | 5.69 Million | -26.49 Million |
NWTN
MPILCORPL
002887
603828
012280
BAY-R